Literature DB >> 4138107

Glucagon control of fasting glucose in man.

F P Alford, S R Bloom, J D Nabarro, R Hall, G M Besser, D H Coy, A J Kastin, A V Schally.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4138107     DOI： 10.1016/s0140-6736(74)92071-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  24 in total

1.  Clinical evaluation of somatostatin as a potential ajunct to insulin in the management of diabetes mellitus.

Authors:  J E Gerich; T A Schultz; S B Lewis; J H Karam
Journal:  Diabetologia       Date:  1977-09       Impact factor: 10.122

2.  The gut as an endocrine organ.

Authors:  K D Buchanan
Journal:  Ir J Med Sci       Date:  1976-12       Impact factor: 1.568

3.  Somatostatin infusion in liver cirrhosis: glucagon control of glucose homeostasis.

Authors:  A V Greco; L Altomonte; G Ghirlanda; A G Rebuzzi; R Manna; A Bertoli
Journal:  Diabetologia       Date:  1980-03       Impact factor: 10.122

Review 4.  Somatostatin.

Authors:  S R Bloom; J M Polak
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

5.  Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.

Authors:  J E Gerich; M Lorenzi; D M Bier; E Tsalikian; V Schneider; J H Karam; P H Forsham
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

6.  Effect of somatostatin on metabolic and hormonal changes induced by nicotinic acid in insulin-dependent diabetics.

Authors:  A S Luyckx; P J Lefebvre
Journal:  Diabetologia       Date:  1976-10       Impact factor: 10.122

7.  Coagulation studies and platelet function after somatostatin infusion.

Authors:  H Rasche; S Raptis; R Scheck; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1976-10-15

8.  Neutralization of glucagon by antiserum as a tool in glucagon physiology. Lack of depression of basal blood glucose after antiserum treatment in rats.

Authors:  J J Holst; H Galbo; E A Richter
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action.

Authors:  Kristine J Hare; Tina Vilsbøll; Meena Asmar; Carolyn F Deacon; Filip K Knop; Jens J Holst
Journal:  Diabetes       Date:  2010-02-11       Impact factor: 9.461

10.  Glucagon levels in normal and diabetic subjects: use of a specific immunoabsorbent for glucagon radioimmunoassay.

Authors:  F P Alford; S R Bloodm; J D Nabarro
Journal:  Diabetologia       Date:  1977-01       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.